Clinical Decision-Making with ctDNA in Bladder Cancer Practice - Seth Lerner, Andrea Apolo & Jeffrey Ross
Clinical Decision-Making with ctDNA in Bladder Cancer Practice - Seth Lerner, Andrea Apolo & Jeffrey Ross UroToday
Clinical Decision-Making with ctDNA in Bladder Cancer Practice - Seth Lerner, Andrea Apolo & Jeffrey Ross UroToday
'Cried and cried': How a breast cancer trial changed the lives of survivors ABC News & Headlines – Australian Broadcasting Corporation
Rural Cancer Patients Get a Lifeline as Dresden Team Pilots Regional Tumour Network Bioengineer.org
Novel CAR-T Therapy for Hard-to-Treat Multiple Myeloma Shows Promising Safety and Durable Responses | Newswise newswise.com
A real-world study of 8,391 patients found that autonomous artificial intelligence (AI) could free up enough clinical capacity to provide more than 8,500 additional face-to-face dermatology appointments across two U.K. hospitals over 16 months.
Хошимин: Число онкологических больных, обращающихся за лечением, растет, но диагностическое оборудование для визуализации по-прежнему не используется. Vietnam.vn
Biomarkers in Colorectal Cancer: Key Types and Their Role in Treatment Oncology News Central
Can Personalized Dosing Improve Life With Metastatic Breast Cancer? Technology Networks
The Hidden Cost of Cancer Care: How Much of Patients’ Lives Is Lost to Treatment Time? Bioengineer.org
A new study from the Institute for Health Metrics and Evaluation (IHME) finds that chewing tobacco use contributed to an estimated 251,000 deaths globally in 2023, with health loss overwhelmingly concentrated in South Asia.
3rd Annual Cleveland Clinic Cancer Conference: Innovations in Multidisciplinary Care Oncodaily
National Cancer Institute Highlights Cancer Research Advances and Priorities for Accelerating Progress Oncodaily
Texas Oncology Expands Cancer Care With New McAllen West Clinic Mega Doctor News
A genetic vulnerability in clear cell renal cell carcinoma, the most aggressive type of kidney cancer, may lend itself to a combination treatment strategy that causes the cancer cells to self-destruct, according to recent research published in the Proceedings of the National Academy of Sciences.
SERD Combination Slows Breast Cancer After CDK4/6 Inhibitor Progression MedPage Today